体外診断(IVD)の中国市場

調査会社DPI Research社が発行したリサーチレポート(データ管理コード:DPI80504)
◆英語タイトル:China In Vitro Diagnostics (IVD) Market Analysis 2012 – 2017 and Forecast 2018 - 2025: Clinical Chemistry,Immunoassay,Molecular Testing,SMBG,Point of Care Testing (POCT), Hematology,Coagulation,Microbiology,Genetic Testing,Infectious Diagnostics,Histology and Cytology
◆発行会社/調査会社:DPI Research
◆商品コード:DPI80504
◆発行日:2018年4月2日
◆調査対象地域:中国
◆産業分野:医療
◆ページ数:85
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD900 ⇒換算¥101,700見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD1,500 ⇒換算¥169,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DPI Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[体外診断(IVD)の中国市場]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

China in vitro diagnostics(IVD) market is anticipated to grow over US$ 11 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 – 2025.
The market is driven by number of factors such as rising incidences of chronic lifestyle diseases, public health awareness, demand of tests in rural areas stimulated by the healthcare reform plan, increasing demand from the middle class for high–end products and an increase in the number of private hospitals and independent testing laboratories.

“China In Vitro Diagnostics (IVD) Market Analysis 2012 – 2017 and Forecast 2018 – 2025: Clinical Chemistry,Immunoassay,Molecular Testing,SMBG,Point of Care Testing (POCT), Hematology,Coagulation,Microbiology,Genetic Testing,Infectious Diagnostics,Histology and Cytology” presents an in-depth assessment of the in vitro diagnostics(IVD) market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for in vitro diagnostics(IVD) in China. The research includes historic data from 2012 to 2017 and forecasts until 2025.

The report contains a granular analysis of the China in vitro diagnostics market segmentation by 11 applications and illustrative forecast to 2025.A comprehensive analysis has been done on market share of China in vitro diagnostics by application, end-user and company share by revenue.

The report also includes assessment of in vitro diagnostics regulation in China.Key trends in terms of partnerships and recent developments are analyzed with details. The report also explores detailed description of growth drivers,restraints, trends and opportunities of the China in vitro diagnostics market.

Market Segmentation by Application and Analysis (2012 – 2025)

• Clinical Chemistry
• Immunoassay
• Molecular Testing
• Self–Monitoring of Blood Glucose (SMBG)
• Point of Care Testing (POCT)
• Hematology
• Coagulation
• Microbiology
• Genetic Testing
• Infectious Diagnostics
• Histology and Cytology

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

• Roche Diagnostics
• Abbott Laboratories
• Siemens Healthineers
• Sysmex Corporation
• Mindray Medical International Limited
• Beckman Coulter Inc
• Shanghai Fosun Pharmaceutical Group
• Thermo Fisher Scientific Inc
• Hologic Inc
• Qiagen
• Cepheid
• Bio-Rad Laboratories Inc
• Da An Gene Co. Ltd
• Shanghai Kehua Bio–Engineering Co. Ltd.

The Latest Industry Data Included in this Report:

• China In Vitro Diagnostics Market Revenue & Forecast (2012 – 2025)
• China In Vitro Diagnostics Market Dynamics
• China In Vitro Diagnostics Market Segmentation by Application (2012 – 2025)
• China In Vitro Diagnostics Market Revenue Share by Application (2012 – 2025)
• China In Vitro Diagnostics Market, Company Share by Revenue, 2017
• China In Vitro Diagnostics Market Share by End-User (Hospitals, Homecare, Research Institutes, Independent laboratories),2017
• Assessmentof In Vitro Diagnostics Regulation in China
• Major Partnership Deals in China In Vitro Diagnostics Market
• Recent Developments in China In Vitro Diagnostics Market
• Overview of Key Companies in China In Vitro Diagnostics Market

*** レポート目次(コンテンツ)***

1. Executive Summary

2. China In Vitro Diagnostics Market Revenue & Forecast (2012 – 2025)

3. China In Vitro Diagnostics Market Revenue Share by Application (2012 – 2025)

4. China In Vitro Diagnostics Market, Company Share by Revenue, 2017

5. China In Vitro Diagnostics Market Dynamics
5.1 Drivers
5.2 Restraints
5.3 Trends & Opportunities

6. China In Vitro Diagnostics Market Segmentation by Application (2012 – 2025)
6.1 Clinical Chemistry
6.2 Immunoassay
6.3 Molecular Testing
6.4 Self–Monitoring of Blood Glucose (SMBG)
6.5 Point of Care Testing (POCT)
6.6 Hematology
6.7 Coagulation
6.8 Microbiology
6.9 Genetic Testing
6.10 Infectious Diagnostics
6.11 Histology and Cytology

7. China In Vitro Diagnostics Market Share by End-User (Hospitals, Homecare, Research Institutes, Independent laboratories),2017

8. Assessment of In Vitro Diagnostics Regulation in China

9. Major Partnership Deals in China In Vitro Diagnostics Market

10. Recent Developments in China In Vitro Diagnostics Market

11. Overview of Key Companies in China In Vitro Diagnostics Market
11.1 Roche Diagnostics
11.1.1 Company Overview
11.2 Abbott Laboratories
11.2.1 Company Overview
11.3 Siemens Healthineers
11.3.1 Company Overview
11.4 Sysmex Corporation
11.4.1 Company Overview
11.5 Mindray Medical International Limited
11.5.1 Company Overview
11.6 Beckman Coulter Inc
11.6.1 Company Overview
11.7 Shanghai Fosun Pharmaceutical Group
11.7.1 Company Overview
11.8 Thermo Fisher Scientific Inc
11.8.1 Company Overview
11.9 Hologic Inc
11.9.1 Company Overview
11.10 Qiagen
11.10.1 Company Overview
11.11 Cepheid
11.11.1 Company Overview
11.12 Bio-Rad Laboratories Inc
11.12.1 Company Overview
11.13 Da An Gene Co. Ltd
11.13.1 Company Overview
11.14 Shanghai Kehua Bio–Engineering Co. Ltd.
11.14.1 Company Overview

Table 3–1: China In Vitro Diagnostics Market Revenue Share(Percent),2012 – 2017
Table 3–2: China In Vitro Diagnostics Market Revenue Share Forecast(Percent),2018 – 2025


Figure 2 1: China In Vitro Diagnostics Market Revenue (Million US$), 2012 – 2017
Figure 2 2: China In Vitro Diagnostics Market Revenue Forecast (Million US$), 2018 – 2025
Figure 4 1: China In Vitro Diagnostics Market, Company Share by Revenue (Percent), 2017
Figure 6 1: China Clinical Chemistry Market Revenue (Million US$), 2012 – 2017
Figure 6 2: China Clinical Chemistry Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6 3: China Immunoassay Market Revenue (Million US$), 2012 – 2017
Figure 6 4: China Immunoassay Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6 5: China Molecular Testing Market Revenue (Million US$), 2012 – 2017
Figure 6 6: China Molecular Testing Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6 7: China SMBG Market Revenue (Million US$), 2012 – 2017
Figure 6 8: China SMBG Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6 9: China POCT Market Revenue (Million US$), 2012 – 2017
Figure 6 10: China POCT Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6 11: China Hematology Market Revenue (Million US$), 2012 – 2017
Figure 6 12: China Hematology Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6 13: China Coagulation Market Revenue (Million US$), 2012 – 2017
Figure 6 14: China Coagulation Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6 15: China Microbiology Market Revenue (Million US$), 2012 – 2017
Figure 6 16: China Microbiology Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6 17: China Genetic Testing Market Revenue (Million US$), 2012 – 2017
Figure 6 18: China Genetic Testing Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6 19: China Infectious Diagnostics Market Revenue (Million US$), 2012 – 2017
Figure 6 20: China Infectious Diagnostics Market Revenue Forecast (Million US$), 2018 – 2025
Figure 6 21: China Histology and Cytology Market Revenue (Million US$), 2012 – 2017
Figure 6 22: China Histology and Cytology Market Revenue Forecast (Million US$), 2018 – 2025
Figure 7 1: China In Vitro Diagnostics Market Share by End-User(Percent),2017



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DPI80504 )"体外診断(IVD)の中国市場" (英文:China In Vitro Diagnostics (IVD) Market Analysis 2012 – 2017 and Forecast 2018 - 2025: Clinical Chemistry,Immunoassay,Molecular Testing,SMBG,Point of Care Testing (POCT), Hematology,Coagulation,Microbiology,Genetic Testing,Infectious Diagnostics,Histology and Cytology)はDPI Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。